Clinical Trials Logo

Intravenous clinical trials

View clinical trials related to Intravenous.

Filter by:
  • None
  • Page 1

NCT ID: NCT04618965 Not yet recruiting - Dexmedetomidine Clinical Trials

Intrathecal Versus Intravenous Dexmeditomedine in Transurethral Resection of the Prostate

Start date: November 1, 2020
Phase: Phase 4
Study type: Interventional

This study is to evaluate The analgesic effect of intrathecal versus intravenous dexmeditomedine in transurethral resection of the prostate

NCT ID: NCT04429282 Recruiting - Pain Clinical Trials

A Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial of Intravenous Ibuprofen 400 and 800 mg Every 6 Hours in the Management of Postoperative Pain.

Start date: June 10, 2020
Phase: Phase 3
Study type: Interventional

This study was to evaluate the efficacy and safety of intravenously administered ibuprofen 400mg and 800 mg q6h for the management of moderate to severe postoperative pain in Chinese population.

NCT ID: NCT01969981 Completed - Anesthesia Clinical Trials

A Study to Assess Placement and Confirmation of Peripheral Inserted Central Catheters Tip Position Using a New Electrocardiographic Method

SHERLOCK 3CG
Start date: October 2013
Phase: N/A
Study type: Observational

This is a prospective, single center, observational study. Patients who require a Peripheral Inserted Central Catheters (PICC) will constitute the study population. The purpose of the study is to determine whether Sherlock 3CG, is adequate means for the total placement of PICC and confirmation of tip of PICC placement and if this method can be conducted safely and efficiently. Patients will be included during a 6-month period as well as they are ambulatory or hospitalized. The patient's routine care will not be modified and only PICC will be assessed in the present study. PICC placement will be performed using the Site Rite guidance and tip position will be confirmed using the Sherlock 3CG. The procedure is the same as the routine habits of the operator (nurse or anesthesiologist); the vascular access team already uses the previous device for CVC placement. Patients won't be followed up in the study.